AIL
ABBV icon

AGF Investments LLC’s AbbVie ABBV Stock Holding History

AGF Investments LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-724
Closed -$111K – 287
2022
Q2 		$111K Buy
724
+457
+171% +$69.8K 0.01% 261
2022
Q1 		$43K Sell
267
-48
-15% -$6.97K ﹤0.01% 351
2021
Q4 		$43K Sell
315
-2,752
-90% -$325K ﹤0.01% 337
2021
Q3 		$331K Sell
3,067
-206
-6% -$23.5K 0.03% 263
2021
Q2 		$369K Sell
3,273
-8
-0.2% -$901 0.04% 258
2021
Q1 		$355K Sell
3,281
-993
-23% -$106K 0.04% 251
2020
Q4 		$458K Sell
4,274
-2,823
-40% -$271K 0.05% 251
2020
Q3 		$622K Sell
7,097
-9,273
-57% -$873K 0.07% 231
2020
Q2 		$1.61M Sell
16,370
-2,324
-12% -$205K 0.16% 78
2020
Q1 		$1.42M Sell
18,694
-5,278
-22% -$450K 0.18% 62
2019
Q4 		$2.12M Buy
23,972
+3,939
+20% +$327K 0.39% 63
2019
Q3 		$1.52M Sell
20,033
-5,112
-20% -$350K 0.36% 76
2019
Q2 		$1.83M Sell
25,145
-29,479
-54% -$2.32M 0.38% 78
2019
Q1 		$4.4M Sell
54,624
-31,932
-37% -$2.61M 0.99% 23
2018
Q4 		$7.98M Buy
86,556
+3,555
+4% +$313K 1.1% 21
2018
Q3 		$7.85M Buy
83,001
+26,886
+48% +$2.55M 1% 29
2018
Q2 		$5.2K Buy
56,115
+30,674
+121% +$3M 0.6% 45
2018
Q1 		$2.41M Buy
25,441
+25,225
+11,678% +$2.77M 0.41% 60
2017
Q4 		$21K Buy
+216
New +$20.4K ﹤0.01% 385
2017
Q3 		– Sell
-1,539
Closed -$111K – 751
2017
Q2 		$111K Buy
1,539
+963
+167% +$64.7K 0.03% 218
2017
Q1 		$38K Sell
576
-232
-29% -$14.6K 0.01% 242
2016
Q4 		$51K Buy
+808
New +$49.3K 0.01% 257

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AGF Investments LLC's ABBV Position: Q3 2022 in Review

AGF Investments LLC sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 724 shares — an estimated $111K sold.

AGF Investments LLC first reported a position in ABBV in Q4 2016 and held it in 22 quarters. The position peaked at $7.98M in Q4 2018. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • AGF Investments LLC reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
  • AGF Investments LLC sold 724 AbbVie shares in Q3 2022, an estimated $111K.
  • AGF Investments LLC first reported a position in AbbVie in Q4 2016 and held it in 22 quarters.
  • AGF Investments LLC's AbbVie position peaked at $7.98M in Q4 2018.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.